Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARTAI: Sintilimab + Radiation in Thoracic Cancer
NCT03732430Phase 2Unknown
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Nov 2018
- Primary completion
- Dec 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in thoracic cancer, sponsored by Taizhou Hospital of Zhejiang Province. Status: unknown.
02
Drugs
sintilimab
03
Conditions
thoracic cancer
Beyond the preview
Go deeper on NCT03732430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732430.